The association of Hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users

Lynne Strasfeld, Yungtai Lo, Dale Netski, David L. Thomas, Robert S. Klein

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Factors associated with serum HCV antibody, HCV RNA level, and HCV genotype were assessed in 557 current and former drug users. Additional assays included HIV antibody, CD4+ lymphocyte counts, HIV viral loads, and hepatitis B markers. Seventy-five percent of subjects were anti-HCV positive, of whom 75% had detectable HCV RNA (median, 5.04 × 105 IU/mL; range, 1020-15.7 ± 106). On multivariate analysis HCV seropositivity was associated with history of drug injection, HIV seropositivity, and increased age and inversely with drug snorting. Among anti-HCV-positive persons, detectable HCV RNA was independently associated with HIV seropositivity, male gender, and history of injection and inversely associated with hepatitis B surface antigen positivity. Among persons with detectable HCV RNA, higher levels were independently associated with higher HIV viral load, increased age, and genotypes 2a and 2b. These findings demonstrate an association of HCV RNA level with HIV viral load, independent of the level of immunosuppression. However, a substantial degree of the person-to-person variability in the prevalence and level of detectable HCV RNA remains unexplained.

Original languageEnglish (US)
Pages (from-to)356-364
Number of pages9
JournalJournal of Acquired Immune Deficiency Syndromes
Volume33
Issue number3
StatePublished - Jul 1 2003
Externally publishedYes

Fingerprint

Hepatitis C
Drug Users
HIV Infections
Genotype
RNA
Viral Load
HIV Seropositivity
HIV
HIV Antibodies
Injections
Hepatitis C Antibodies
CD4 Lymphocyte Count
Hepatitis B Surface Antigens
Hepatitis B
Pharmaceutical Preparations
Immunosuppression
Multivariate Analysis
Serum

Keywords

  • Drug users
  • HCV
  • Hepatitis C virus
  • RNA level
  • Viral load

ASJC Scopus subject areas

  • Virology
  • Immunology

Cite this

The association of Hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users. / Strasfeld, Lynne; Lo, Yungtai; Netski, Dale; Thomas, David L.; Klein, Robert S.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 33, No. 3, 01.07.2003, p. 356-364.

Research output: Contribution to journalArticle

@article{25910d7961d748079b6b5dac009eccd8,
title = "The association of Hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users",
abstract = "Factors associated with serum HCV antibody, HCV RNA level, and HCV genotype were assessed in 557 current and former drug users. Additional assays included HIV antibody, CD4+ lymphocyte counts, HIV viral loads, and hepatitis B markers. Seventy-five percent of subjects were anti-HCV positive, of whom 75{\%} had detectable HCV RNA (median, 5.04 × 105 IU/mL; range, 1020-15.7 ± 106). On multivariate analysis HCV seropositivity was associated with history of drug injection, HIV seropositivity, and increased age and inversely with drug snorting. Among anti-HCV-positive persons, detectable HCV RNA was independently associated with HIV seropositivity, male gender, and history of injection and inversely associated with hepatitis B surface antigen positivity. Among persons with detectable HCV RNA, higher levels were independently associated with higher HIV viral load, increased age, and genotypes 2a and 2b. These findings demonstrate an association of HCV RNA level with HIV viral load, independent of the level of immunosuppression. However, a substantial degree of the person-to-person variability in the prevalence and level of detectable HCV RNA remains unexplained.",
keywords = "Drug users, HCV, Hepatitis C virus, RNA level, Viral load",
author = "Lynne Strasfeld and Yungtai Lo and Dale Netski and Thomas, {David L.} and Klein, {Robert S.}",
year = "2003",
month = "7",
day = "1",
language = "English (US)",
volume = "33",
pages = "356--364",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - The association of Hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users

AU - Strasfeld, Lynne

AU - Lo, Yungtai

AU - Netski, Dale

AU - Thomas, David L.

AU - Klein, Robert S.

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Factors associated with serum HCV antibody, HCV RNA level, and HCV genotype were assessed in 557 current and former drug users. Additional assays included HIV antibody, CD4+ lymphocyte counts, HIV viral loads, and hepatitis B markers. Seventy-five percent of subjects were anti-HCV positive, of whom 75% had detectable HCV RNA (median, 5.04 × 105 IU/mL; range, 1020-15.7 ± 106). On multivariate analysis HCV seropositivity was associated with history of drug injection, HIV seropositivity, and increased age and inversely with drug snorting. Among anti-HCV-positive persons, detectable HCV RNA was independently associated with HIV seropositivity, male gender, and history of injection and inversely associated with hepatitis B surface antigen positivity. Among persons with detectable HCV RNA, higher levels were independently associated with higher HIV viral load, increased age, and genotypes 2a and 2b. These findings demonstrate an association of HCV RNA level with HIV viral load, independent of the level of immunosuppression. However, a substantial degree of the person-to-person variability in the prevalence and level of detectable HCV RNA remains unexplained.

AB - Factors associated with serum HCV antibody, HCV RNA level, and HCV genotype were assessed in 557 current and former drug users. Additional assays included HIV antibody, CD4+ lymphocyte counts, HIV viral loads, and hepatitis B markers. Seventy-five percent of subjects were anti-HCV positive, of whom 75% had detectable HCV RNA (median, 5.04 × 105 IU/mL; range, 1020-15.7 ± 106). On multivariate analysis HCV seropositivity was associated with history of drug injection, HIV seropositivity, and increased age and inversely with drug snorting. Among anti-HCV-positive persons, detectable HCV RNA was independently associated with HIV seropositivity, male gender, and history of injection and inversely associated with hepatitis B surface antigen positivity. Among persons with detectable HCV RNA, higher levels were independently associated with higher HIV viral load, increased age, and genotypes 2a and 2b. These findings demonstrate an association of HCV RNA level with HIV viral load, independent of the level of immunosuppression. However, a substantial degree of the person-to-person variability in the prevalence and level of detectable HCV RNA remains unexplained.

KW - Drug users

KW - HCV

KW - Hepatitis C virus

KW - RNA level

KW - Viral load

UR - http://www.scopus.com/inward/record.url?scp=0037488418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037488418&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 356

EP - 364

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 3

ER -